A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study

Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism
Michel ReynaudMichel Detilleux

Abstract

Alcohol dependence is a major public health issue with a need for new pharmacological treatments. The ALPADIR study assessed the efficacy and safety of baclofen at the target dose of 180 mg/day for the maintenance of abstinence and the reduction in alcohol consumption in alcohol-dependent patients. Three hundred and twenty adult patients (158 baclofen and 162 placebo) were randomized after alcohol detoxification. After a 7-week titration, the maintenance dose was provided for 17 weeks, then progressively decreased over 2 weeks before stopping. The percentage of abstinent patients during 20 consecutive weeks (primary endpoint) was low (baclofen: 11.9%; placebo: 10.5%) and not significantly different between groups (OR 1.20; 95%CI: 0.58 to 2.50; P = 0.618). A reduction in alcohol consumption was observed from month 1 in both groups, but the difference of 10.9 g/day at month 6 between groups, in favour of baclofen, was not statistically significant (P = 0.095). In a subgroup of patients with high drinking risk level at baseline, the reduction was greater with a difference at month 6 of 15.6 g/day between groups in favour of baclofen (P = 0.089). The craving assessed with Obsessive-Compulsive Drinking Scale significantly decreased ...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoGiovanni Gasbarrini
Jan 28, 2004·Alcoholism, Clinical and Experimental Research·Karl MannMarsha Y Morgan
Dec 15, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Olivier Ameisen
Feb 4, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Laurent MaletBruno Falissard
May 27, 2006·Journal of Psychiatric Practice·Aron N StarostaJoseph R Volpicelli
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Lorenzo LeggioGiovanni Addolorato
Jul 29, 2010·Alcoholism, Clinical and Experimental Research·James C GarbuttBarbara A Flannery
Mar 19, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoUNKNOWN Baclofen Study Group
Jul 12, 2011·Journal of Psychopharmacology·Jonathan Chick, David J Nutt
Sep 8, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H U WittchenH-C Steinhausen
Feb 14, 2012·Addiction·Benjamin RollandOlivier Cottencin
Mar 22, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Laurent RigalPhilippe Jaury
Feb 21, 2013·Journal of Clinical Psychopharmacology·Benjamin RollandOlivier Cottencin
Jul 31, 2013·Alcoholism, Clinical and Experimental Research·Kevin A Hallgren, Katie Witkiewitz
Oct 25, 2014·European Addiction Research·Jürgen RehmGerhard Gmel
Oct 28, 2014·Alcoholism, Clinical and Experimental Research·Ralitza GueorguievaStephanie S O'Malley
Nov 26, 2014·Alcoholism, Clinical and Experimental Research·Katie WitkiewitzUNKNOWN Alcohol Clinical Trials Initiative (ACTIVE) Workgroup
Jun 7, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Christian A MüllerAndreas Heinz
Jun 20, 2015·Current Pharmaceutical Design·Antonio MirijelloGiovanni Addolorato
Jul 25, 2015·Alcoholism, Clinical and Experimental Research·Bruce ImbertNicolas Simon
Mar 2, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Raye Z LittenJoanne B Fertig
Nov 16, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Esther M BerahaReinout W Wiers

❮ Previous
Next ❯

Citations

Apr 6, 2018·Journal of Clinical Psychopharmacology·Cecile ChevallierSamira Djezzar
Apr 6, 2018·Journal of Clinical Psychopharmacology·Léa Hamel SénécalReynald Le Boisselier
May 3, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Kirsten C MorleyPaul S Haber
Oct 17, 2017·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Maxime LégerDavid Boels
Jun 12, 2018·Acta Psychiatrica Scandinavica·T BschorC Baethge
Oct 24, 2018·Alcoholism, Clinical and Experimental Research·Henri-Jean Aubin, Karl Mann
Dec 14, 2018·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Miho Terunuma
Nov 10, 2017·Expert Opinion on Drug Safety·Mariangela AntonelliGiovanni Addolorato
Apr 13, 2019·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Susan A RomboutsKirsten C Morley
Feb 20, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alain Braillon, Florian Naudet
Nov 26, 2019·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Benjamin RollandHenri-Jean Aubin
Nov 26, 2019·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Alain BraillonJoel Lexchin
Aug 23, 2017·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Alain Braillon, Florian Naudet
Sep 7, 2017·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Nicolas FranchittoFanny Pélissier
Jun 27, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Magali ChartierBruno Mégarbane
Jun 23, 2018·Science·Rainer Spanagel
Sep 7, 2018·Frontiers in Psychiatry·Benjamin RollandNicolas Franchitto
Sep 1, 2018·JAMA : the Journal of the American Medical Association·Richard Saitz
Nov 22, 2018·Frontiers in Psychiatry·Renaud de Beaurepaire
Mar 15, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Linn M EvensethIngebrigt Sylte
Sep 8, 2018·Frontiers in Psychiatry·Nicolas SimonBenjamin Rolland
Sep 1, 2018·JAMA : the Journal of the American Medical Association·Henry R Kranzler, Michael Soyka
Jan 22, 2019·Frontiers in Psychiatry·Renaud de BeaurepaireRoberta Agabio
Mar 27, 2018·Psychopharmacology·Erin J CampbellChristina J Perry
Nov 30, 2018·The Cochrane Database of Systematic Reviews·Silvia MinozziSusanne Rösner
May 21, 2019·Current Opinion in Psychiatry·Mehdi FarokhniaLorenzo Leggio
Sep 21, 2018·Frontiers in Psychiatry·Nicolas FranchittoNicolas Simon
Oct 17, 2018·Frontiers in Psychiatry·Roberta Agabio, Lorenzo Leggio
Jul 23, 2020·Der Nervenarzt·Michael Soyka, Susanne Rösner
Feb 10, 2021·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Eric Augier
May 22, 2020·ACS Chemical Neuroscience·Caitlin N KentCraig W Lindsley
Apr 2, 2021·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Nicholas LivingstonChristine Timko
Jul 22, 2018·Neuropharmacology·María Carmen González-MarínMickaël Naassila
Dec 2, 2017·Pharmacology & Therapeutics·Mohammed AkbarAntonio Noronha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.